Pulmonary arterial hypertension
Not yet recruitingEfficacy and Safety of Sodium Valproate Added to Standard Therapy in Patients with Stable Pulmonary Arterial Hypertension – Phase 2b Randomized Study
Efficacy and Safety of Sodium Valproate Added to Standard Therapy in Patients with Stable Pulmonary Arterial Hypertension – Phase 2b Randomized Study
- Disease:Pulmonary arterial hypertension
- Substances:Sodium Valproate
France- Participants:18–64 years · 65+ years
- Substances:Sodium Valproate
- Sponsor:Cereno Scientific AB


